|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net (Note 3) | ||||||||||||||||||
| Deposits | ||||||||||||||||||
| Operating lease right-of-use asset (Note 6) | ||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||
| Intangible assets, net (Note 4) | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued expenses (Note 5) | ||||||||||||||||||
| Current portion of accrued commissions | ||||||||||||||||||
| Current portion of operating lease liability (Note 6) | ||||||||||||||||||
| Current portion of contingent consideration (Note 10) | ||||||||||||||||||
| Convertible notes (Note 7) | ||||||||||||||||||
| Derivative liability (Note 8) | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Accrued commissions, net of current portion | ||||||||||||||||||
| Operating lease liability, net of current portion (Note 6) | ||||||||||||||||||
| Contingent consideration, net of current portion (Note 10) | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ (deficit) equity: | ||||||||||||||||||
| Convertible preferred stock, value | ||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||
| Series B Convertible Preferred Stock | ||||||||||||||||||
| Common stock, $0.001 par value; 130,000,000 shares authorized at June 30, 2026 and December 31, 2025; 330,670 and 310,036 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Total stockholders’ (deficit) equity | ||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY | ||||||||||||||||||
Loading...